A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...

While Ozempic and other drugs like it have proven effective in helping people lose weight, many gain it back when the ...

Swiss drugmaker Roche signalled its ambition to join Eli Lilly and Novo Nordisk at the top of the booming weight-loss market ...

Patients taking a daily weight-loss pill lost up to 12% of their body weight in a global trial, according to the Cornell ...

GLP-1 drugs are reshaping our bodies, but also our society. They may even help to treat major diseases once thought incurable.

By Andrew Silver SHANGHAI (Reuters) -Innovent Biologics' newly launched weight-loss drug is making inroads in its home market ...

Pfizer has agreed to pay up to $7.3 billion for weight-loss drug developer Metsera in a deal that gets the New York drugmaker ...

Medically reviewed by Femi Aremu, PharmD Key Takeaways While both contain semaglutide, Wegovy is approved specifically for weight management, whereas Ozempic is approved for the treatment of type 2 ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

We are undertaking that process now and I would expect we’ll have a lot to say about that come December in my budget speech,” ...

Tennis goat Serena Williams has been on a losing streak since she hung up her racket three years ago – the 23-time Grand Slam winner has shed 31 pounds with the help of the weight-loss drug Zepbound, ...